The Value of Real-Time CGM to Reduce Diabetes Costs

The Value of Real-Time CGM to Reduce Diabetes Costs is organized by Impact Education, LLC.

Release Date: November 30, 2020
Expiration Date: May 31, 2022

Target Audience:
This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals

Statement of Need/Program Overview:
Payers and employers alike place precedence on the clinical and economic burden of diabetes but are often unaware of the potential cost offsets garnered through effective, evidence-based therapy and emerging health technology interventions. In addition, the vast majority of plan members with diabetes have an A1C above ADA targets, putting them at risk for other costly comorbidities. Imprecise diabetes management culminating in hypoglycemic events can further result in excess health care resource utilization and reduced quality of life among members. To effectively address these clinical challenges and elicit improvements across 29 indices of glycemic variability and control, continuous glucose monitoring (CGM) has been endorsed by various professional endocrinology-centered organizations. This program will elucidate the clinical and economic burden of diabetes and describe multifaceted clinical and administrative strategies across the medical and pharmacy benefits to promote quality care and mitigate costs while improving outcomes for affected plan members.

Educational Objectives:
After completing this activity, the participant should be better able to: 
• Describe the impact of real-time CGM and remote monitoring on improving outcomes and reducing costs in high-risk, high-utilizing patient populations
• Assess the clinical and economic benefits of using real-time CGM over self-monitoring of blood glucose in Medicaid and Medicare plan beneficiaries
• Review the status of ongoing plan initiatives measuring the impact of real-time CGM on health status and utilization outcomes
• Characterize the role of real-time CGM as part of an employer-driven, population health management strategy
• Identify appropriate benefit design strategies to reduce health care system burden and improve quality, clinical, and economic outcomes